Request for Covid-19 Impact Assessment of this Report

Pharmaceuticals

Global Biosimilars Market Professional Survey Report 2016

  • QYR681193
  • 114 Pages
  • September 2016
  • Pharmaceuticals
Download Sample    Get Discount   
 
Notes:

Production, means the output of Biosimilars

Revenue, means the sales value of Biosimilars

This report studies Biosimilars in Global market, especially in North America, Europe, China, Japan, Southeast Asia and India, with production, revenue, consumption, import and export in these regions, from 2011 to 2015, and forecast to 2021.

This report focuses on top manufacturers in global market, with production, price, revenue and market share for each manufacturer, covering

Roche

Amgen

AbbVie

Sanofi-Aventis

Johnson & Johnson

Pfizer

Novo Nordisk

Eli Lilly

Novartis

Merck

3sbio

Changchun High Tech

CP Guojian

Biotech

Gelgen

Innovent

By types, the market can be split into

Antibody

Hormone

Growth Factors

Others

By Application, the market can be split into

Tumor

Diabetes

Cardiovascular

Hemophilia

Others

By Regions, this report covers (we can add the regions/countries as you want)

North America

China

Europe

Southeast Asia

Japan

India

Table of Contents

Global Biosimilars Market Professional Survey Report 2016

1 Industry Overview of Biosimilars

1.1 Definition and Specifications of Biosimilars

1.1.1 Definition of Biosimilars

1.1.2 Specifications of Biosimilars

1.2 Classification of Biosimilars

1.2.1 Antibody

1.2.2 Hormone

1.2.3 Growth Factors

1.2.4 Others

1.3 Applications of Biosimilars

1.3.1 Tumor

1.3.2 Diabetes

1.3.3 Cardiovascular

1.3.4 Hemophilia

1.3.5 Others

1.4 Market Segment by Regions

1.4.1 North America

1.4.2 China

1.4.3 Europe

1.4.4 Southeast Asia

1.4.5 Japan

1.4.6 India

2 Manufacturing Cost Structure Analysis of Biosimilars

2.1 Raw Material and Suppliers

2.2 Manufacturing Cost Structure Analysis of Biosimilars

2.3 Manufacturing Process Analysis of Biosimilars

2.4 Industry Chain Structure of Biosimilars

3 Technical Data and Manufacturing Plants Analysis of Biosimilars

3.1 Capacity and Commercial Production Date of Global Biosimilars Major Manufacturers in 2015

3.2 Manufacturing Plants Distribution of Global Biosimilars Major Manufacturers in 2015

3.3 R&D Status and Technology Source of Global Biosimilars Major Manufacturers in 2015

3.4 Raw Materials Sources Analysis of Global Biosimilars Major Manufacturers in 2015

4 Global Biosimilars Overall Market Overview

4.1 2011-2016E Overall Market Analysis

4.2 Capacity Analysis

4.2.1 2011-2016E Global Biosimilars Capacity and Growth Rate Analysis

4.2.2 2015 Biosimilars Capacity Analysis (Company Segment)

4.3 Sales Analysis

4.3.1 2011-2016E Global Biosimilars Sales and Growth Rate Analysis

4.3.2 2015 Biosimilars Sales Analysis (Company Segment)

4.4 Sales Price Analysis

4.4.1 2011-2016E Global Biosimilars Sales Price

4.4.2 2015 Biosimilars Sales Price Analysis (Company Segment)

5 Biosimilars Regional Market Analysis

5.1 North America Biosimilars Market Analysis

5.1.1 North America Biosimilars Market Overview

5.1.2 North America 2011-2016E Biosimilars Local Supply, Import, Export, Local Consumption Analysis

5.1.3 North America 2011-2016E Biosimilars Sales Price Analysis

5.1.4 North America 2015 Biosimilars Market Share Analysis

5.2 China Biosimilars Market Analysis

5.2.1 China Biosimilars Market Overview

5.2.2 China 2011-2016E Biosimilars Local Supply, Import, Export, Local Consumption Analysis

5.2.3 China 2011-2016E Biosimilars Sales Price Analysis

5.2.4 China 2015 Biosimilars Market Share Analysis

5.3 Europe Biosimilars Market Analysis

5.3.1 Europe Biosimilars Market Overview

5.3.2 Europe 2011-2016E Biosimilars Local Supply, Import, Export, Local Consumption Analysis

5.3.3 Europe 2011-2016E Biosimilars Sales Price Analysis

5.3.4 Europe 2015 Biosimilars Market Share Analysis

5.4 Southeast Asia Biosimilars Market Analysis

5.4.1 Southeast Asia Biosimilars Market Overview

5.4.2 Southeast Asia 2011-2016E Biosimilars Local Supply, Import, Export, Local Consumption Analysis

5.4.3 Southeast Asia 2011-2016E Biosimilars Sales Price Analysis

5.4.4 Southeast Asia 2015 Biosimilars Market Share Analysis

5.5 Japan Biosimilars Market Analysis

5.5.1 Japan Biosimilars Market Overview

5.5.2 Japan 2011-2016E Biosimilars Local Supply, Import, Export, Local Consumption Analysis

5.5.3 Japan 2011-2016E Biosimilars Sales Price Analysis

5.5.4 Japan 2015 Biosimilars Market Share Analysis

5.6 India Biosimilars Market Analysis

5.6.1 India Biosimilars Market Overview

5.6.2 India 2011-2016E Biosimilars Local Supply, Import, Export, Local Consumption Analysis

5.6.3 India 2011-2016E Biosimilars Sales Price Analysis

5.6.4 India 2015 Biosimilars Market Share Analysis

6 Global 2011-2016E Biosimilars Segment Market Analysis (by Type)

6.1 Global 2011-2016E Biosimilars Sales by Type

6.2 Different Types of Biosimilars Product Interview Price Analysis

6.3 Different Types of Biosimilars Product Driving Factors Analysis

6.3.1 Antibody of Biosimilars Growth Driving Factor Analysis

6.3.2 Hormone of Biosimilars Growth Driving Factor Analysis

6.3.3 Growth Factors of Biosimilars Growth Driving Factor Analysis

6.3.4 Others of Biosimilars Growth Driving Factor Analysis

7 Global 2011-2016E Biosimilars Segment Market Analysis (by Application)

7.1 Global 2011-2016E Biosimilars Consumption by Application

7.2 Different Application of Biosimilars Product Interview Price Analysis

7.3 Different Application of Biosimilars Product Driving Factors Analysis

7.3.1 Tumor of Biosimilars Growth Driving Factor Analysis

7.3.2 Diabetes of Biosimilars Growth Driving Factor Analysis

7.3.3 Cardiovascular of Biosimilars Growth Driving Factor Analysis

7.3.4 Hemophilia of Biosimilars Growth Driving Factor Analysis

7.3.5 Others of Biosimilars Growth Driving Factor Analysis

8 Major Manufacturers Analysis of Biosimilars

8.1 Roche

8.1.1 Company Profile

8.1.2 Product Picture and Specifications

8.1.2.1 Type I

8.1.2.2 Type II

8.1.2.3 Type III

8.1.3 Roche 2015 Biosimilars Sales, Ex-factory Price, Revenue, Gross Margin Analysis

8.1.4 Roche 2015 Biosimilars Business Region Distribution Analysis

8.2 Amgen

8.2.1 Company Profile

8.2.2 Product Picture and Specifications

8.2.2.1 Type I

8.2.2.2 Type II

8.2.2.3 Type III

8.2.3 Amgen 2015 Biosimilars Sales, Ex-factory Price, Revenue, Gross Margin Analysis

8.2.4 Amgen 2015 Biosimilars Business Region Distribution Analysis

8.3 AbbVie

8.3.1 Company Profile

8.3.2 Product Picture and Specifications

8.3.2.1 Type I

8.3.2.2 Type II

8.3.2.3 Type III

8.3.3 AbbVie 2015 Biosimilars Sales, Ex-factory Price, Revenue, Gross Margin Analysis

8.3.4 AbbVie 2015 Biosimilars Business Region Distribution Analysis

8.4 Sanofi-Aventis

8.4.1 Company Profile

8.4.2 Product Picture and Specifications

8.4.2.1 Type I

8.4.2.2 Type II

8.4.2.3 Type III

8.4.3 Sanofi-Aventis 2015 Biosimilars Sales, Ex-factory Price, Revenue, Gross Margin Analysis

8.4.4 Sanofi-Aventis 2015 Biosimilars Business Region Distribution Analysis

8.5 Johnson & Johnson

8.5.1 Company Profile

8.5.2 Product Picture and Specifications

8.5.2.1 Type I

8.5.2.2 Type II

8.5.2.3 Type III

8.5.3 Johnson & Johnson 2015 Biosimilars Sales, Ex-factory Price, Revenue, Gross Margin Analysis

8.5.4 Johnson & Johnson 2015 Biosimilars Business Region Distribution Analysis

8.6 Pfizer

8.6.1 Company Profile

8.6.2 Product Picture and Specifications

8.6.2.1 Type I

8.6.2.2 Type II

8.6.2.3 Type III

8.6.3 Pfizer 2015 Biosimilars Sales, Ex-factory Price, Revenue, Gross Margin Analysis

8.6.4 Pfizer 2015 Biosimilars Business Region Distribution Analysis

8.7 Novo Nordisk

8.7.1 Company Profile

8.7.2 Product Picture and Specifications

8.7.2.1 Type I

8.7.2.2 Type II

8.7.2.3 Type III

8.7.3 Novo Nordisk 2015 Biosimilars Sales, Ex-factory Price, Revenue, Gross Margin Analysis

8.7.4 Novo Nordisk 2015 Biosimilars Business Region Distribution Analysis

8.8 Eli Lilly

8.8.1 Company Profile

8.8.2 Product Picture and Specifications

8.8.2.1 Type I

8.8.2.2 Type II

8.8.2.3 Type III

8.8.3 Eli Lilly 2015 Biosimilars Sales, Ex-factory Price, Revenue, Gross Margin Analysis

8.8.4 Eli Lilly 2015 Biosimilars Business Region Distribution Analysis

8.9 Novartis

8.9.1 Company Profile

8.9.2 Product Picture and Specifications

8.9.2.1 Type I

8.9.2.2 Type II

8.9.2.3 Type III

8.9.3 Novartis 2015 Biosimilars Sales, Ex-factory Price, Revenue, Gross Margin Analysis

8.9.4 Novartis 2015 Biosimilars Business Region Distribution Analysis

8.10 Merck

8.10.1 Company Profile

8.10.2 Product Picture and Specifications

8.10.2.1 Type I

8.10.2.2 Type II

8.10.2.3 Type III

8.10.3 Merck 2015 Biosimilars Sales, Ex-factory Price, Revenue, Gross Margin Analysis

8.10.4 Merck 2015 Biosimilars Business Region Distribution Analysis

8.11 3sbio

8.11.1 Company Profile

8.11.2 Product Picture and Specifications

8.11.2.1 Type I

8.11.2.2 Type II

8.11.2.3 Type III

8.11.3 3sbio 2015 Biosimilars Sales, Ex-factory Price, Revenue, Gross Margin Analysis

8.11.4 3sbio 2015 Biosimilars Business Region Distribution Analysis

8.12 Changchun High Tech

8.12.1 Company Profile

8.12.2 Product Picture and Specifications

8.12.2.1 Type I

8.12.2.2 Type II

8.12.2.3 Type III

8.12.3 Changchun High Tech 2015 Biosimilars Sales, Ex-factory Price, Revenue, Gross Margin Analysis

8.12.4 Changchun High Tech 2015 Biosimilars Business Region Distribution Analysis

8.13 CP Guojian

8.13.1 Company Profile

8.13.2 Product Picture and Specifications

8.13.2.1 Type I

8.13.2.2 Type II

8.13.2.3 Type III

8.13.3 CP Guojian 2015 Biosimilars Sales, Ex-factory Price, Revenue, Gross Margin Analysis

8.13.4 CP Guojian 2015 Biosimilars Business Region Distribution Analysis

8.14 Biotech

8.14.1 Company Profile

8.14.2 Product Picture and Specifications

8.14.2.1 Type I

8.14.2.2 Type II

8.14.2.3 Type III

8.14.3 Biotech 2015 Biosimilars Sales, Ex-factory Price, Revenue, Gross Margin Analysis

8.14.4 Biotech 2015 Biosimilars Business Region Distribution Analysis

8.15 Gelgen

8.15.1 Company Profile

8.15.2 Product Picture and Specifications

8.15.2.1 Type I

8.15.2.2 Type II

8.15.2.3 Type III

8.15.3 Gelgen 2015 Biosimilars Sales, Ex-factory Price, Revenue, Gross Margin Analysis

8.15.4 Gelgen 2015 Biosimilars Business Region Distribution Analysis

8.16 Innovent

8.16.1 Company Profile

8.16.2 Product Picture and Specifications

8.16.2.1 Type I

8.16.2.2 Type II

8.16.2.3 Type III

8.16.3 Innovent 2015 Biosimilars Sales, Ex-factory Price, Revenue, Gross Margin Analysis

8.16.4 Innovent 2015 Biosimilars Business Region Distribution Analysis

9 Development Trend of Analysis of Biosimilars Market

9.1 Global Biosimilars Market Trend Analysis

9.1.1 Global 2016-2021 Biosimilars Market Size (Volume and Value) Forecast

9.1.2 Global 2016-2021 Biosimilars Sales Price Forecast

9.2 Biosimilars Regional Market Trend

9.2.1 North America 2016-2021 Biosimilars Consumption Forecast

9.2.2 China 2016-2021 Biosimilars Consumption Forecast

9.2.3 Europe 2016-2021 Biosimilars Consumption Forecast

9.2.4 Southeast Asia 2016-2021 Biosimilars Consumption Forecast

9.2.5 Japan 2016-2021 Biosimilars Consumption Forecast

9.2.6 India 2016-2021 Biosimilars Consumption Forecast

9.3 Biosimilars Market Trend (Product Type)

9.4 Biosimilars Market Trend (Application)

10 Biosimilars Marketing Type Analysis

10.1 Biosimilars Regional Marketing Type Analysis

10.2 Biosimilars International Trade Type Analysis

10.3 Traders or Distributors with Contact Information of Biosimilars by Regions

10.4 Biosimilars Supply Chain Analysis

11 Consumers Analysis of Biosimilars

11.1 Consumer 1 Analysis

11.2 Consumer 2 Analysis

11.3 Consumer 3 Analysis

11.4 Consumer 4 Analysis

12 Conclusion of the Global Biosimilars Market Professional Survey Report 2016

Author List

Table Part of Interviewees Record List

Disclosure Section

Research Methodology

Data Source

China Disclaimer

List Of Tables and Figures

Figure Picture of Biosimilars

Table Product Specifications of Biosimilars

Table Classification of Biosimilars

Figure Global Production Market Share of Biosimilars by Type in 2015

Figure Antibody Picture

Table Major Manufacturers of Antibody

Figure Hormone Picture

Table Major Manufacturers of Hormone

Figure Growth Factors Picture

Table Major Manufacturers of Growth Factors

Figure Others Picture

Table Major Manufacturers of Others

Table Applications of Biosimilars

Figure Global Consumption Volume Market Share of Biosimilars by Application in 2015

Figure Tumor Examples

Table Major Consumers of Tumor

Figure Diabetes Examples

Table Major Consumers of Diabetes

Figure Cardiovascular Examples

Table Major Consumers of Cardiovascular

Figure Hemophilia Examples

Table Major Consumers of Hemophilia

Figure Others Examples

Table Major Consumers of Others

Figure Market Share of Biosimilars by Regions

Figure North America Biosimilars Market Size (2011-2021)

Figure China Biosimilars Market Size (2011-2021)

Figure Europe Biosimilars Market Size (2011-2021)

Figure Southeast Asia Biosimilars Market Size (2011-2021)

Figure Japan Biosimilars Market Size (2011-2021)

Figure India Biosimilars Market Size (2011-2021)

Table Biosimilars Raw Material and Suppliers

Table Manufacturing Cost Structure Analysis of Biosimilars in 2015

Figure Manufacturing Process Analysis of Biosimilars

Figure Industry Chain Structure of Biosimilars

Table Capacity (K Units) and Commercial Production Date of Global Biosimilars Major Manufacturers in 2015

Table Manufacturing Plants Distribution of Global Biosimilars Major Manufacturers in 2015

Table R&D Status and Technology Source of Global Biosimilars Major Manufacturers in 2015

Table Raw Materials Sources Analysis of Global Biosimilars Major Manufacturers in 2015

Table Global Capacity (K Units), Sales (K Units), Price (USD/Unit), Cost (USD/Unit), Sales Revenue (M USD) and Gross Margin of Biosimilars 2011-2016

Figure Global 2011-2016E Biosimilars Market Size (Volume) and Growth Rate

Figure Global 2011-2016E Biosimilars Market Size (Value) and Growth Rate

Table 2011-2016E Global Biosimilars Capacity and Growth Rate

Table 2015 Global Biosimilars Capacity List (Company Segment)

Table 2011-2016E Global Biosimilars Sales and Growth Rate

Table 2015 Global Biosimilars Sales List (Company Segment)

Table 2011-2016E Global Biosimilars Sales Price

Table 2015 Global Biosimilars Sales Price List (Company Segment)

Figure North America Capacity Overview

Table North America Supply, Import, Export and Consumption of Biosimilars 2011-2016 (K Units)

Figure North America 2011-2016E Biosimilars Sales Price (USD/Unit)

Figure North America 2015 Biosimilars Sales Market Share

Figure China Capacity Overview

Table China Supply, Import, Export and Consumption of Biosimilars 2011-2016 (K Units)

Figure China 2011-2016E Biosimilars Sales Price (USD/Unit)

Figure China 2015 Biosimilars Sales Market Share

Figure Europe Capacity Overview

Table Europe Supply, Import, Export and Consumption of Biosimilars 2011-2016 (K Units)

Figure Europe 2011-2016E Biosimilars Sales Price (USD/Unit)

Figure Europe 2015 Biosimilars Sales Market Share

Figure Southeast Asia Capacity Overview

Table Southeast Asia Supply, Import, Export and Consumption of Biosimilars 2011-2016 (K Units)

Figure Southeast Asia 2011-2016E Biosimilars Sales Price (USD/Unit)

Figure Southeast Asia 2015 Biosimilars Sales Market Share

Figure Japan Capacity Overview

Table Japan Supply, Import, Export and Consumption of Biosimilars 2011-2016 (K Units)

Figure Japan 2011-2016E Biosimilars Sales Price (USD/Unit)

Figure Japan 2015 Biosimilars Sales Market Share

Figure India Capacity Overview

Table India Supply, Import, Export and Consumption of Biosimilars 2011-2016 (K Units)

Figure India 2011-2016E Biosimilars Sales Price (USD/Unit)

Figure India 2015 Biosimilars Sales Market Share

Table Global 2011-2016E Biosimilars Sales by Type

Table Different Types Biosimilars Product Interview Price

Table Global 2011-2016E Biosimilars Sales by Application

Table Different Application Biosimilars Product Interview Price

Table Roche Information List

Table Type I Biosimilars Overview

Table Type II Biosimilars Overview

Table Type III Biosimilars Overview

Table 2015 Roche Biosimilars Revenue, Sales, Ex-factory Price

Figure 2015 Roche 2015 Biosimilars Business Region Distribution

Table Amgen Information List

Table Type I Biosimilars Overview

Table Type II Biosimilars Overview

Table Type III Biosimilars Overview

Table 2015 Amgen Biosimilars Revenue, Sales, Ex-factory Price

Figure 2015 Amgen 2015 Biosimilars Business Region Distribution

Table AbbVie Information List

Table Type I Biosimilars Overview

Table Type II Biosimilars Overview

Table Type III Biosimilars Overview

Table 2015 AbbVie Biosimilars Revenue, Sales, Ex-factory Price

Figure 2015 AbbVie 2015 Biosimilars Business Region Distribution

Table Sanofi-Aventis Information List

Table Type I Biosimilars Overview

Table Type II Biosimilars Overview

Table Type III Biosimilars Overview

Table 2015 Sanofi-Aventis Biosimilars Revenue, Sales, Ex-factory Price

Figure 2015 Sanofi-Aventis 2015 Biosimilars Business Region Distribution

Table Johnson & Johnson Information List

Table Type I Biosimilars Overview

Table Type II Biosimilars Overview

Table Type III Biosimilars Overview

Table 2015 Johnson & Johnson Biosimilars Revenue, Sales, Ex-factory Price

Figure 2015 Johnson & Johnson 2015 Biosimilars Business Region Distribution

Table Pfizer Information List

Table Type I Biosimilars Overview

Table Type II Biosimilars Overview

Table Type III Biosimilars Overview

Table 2015 Pfizer Biosimilars Revenue, Sales, Ex-factory Price

Figure 2015 Pfizer 2015 Biosimilars Business Region Distribution

Table Novo Nordisk Information List

Table Type I Biosimilars Overview

Table Type II Biosimilars Overview

Table Type III Biosimilars Overview

Table 2015 Novo Nordisk Biosimilars Revenue, Sales, Ex-factory Price

Figure 2015 Novo Nordisk 2015 Biosimilars Business Region Distribution

Table Eli Lilly Information List

Table Type I Biosimilars Overview

Table Type II Biosimilars Overview

Table Type III Biosimilars Overview

Table 2015 Eli Lilly Biosimilars Revenue, Sales, Ex-factory Price

Figure 2015 Eli Lilly 2015 Biosimilars Business Region Distribution

Table Novartis Information List

Table Type I Biosimilars Overview

Table Type II Biosimilars Overview

Table Type III Biosimilars Overview

Table 2015 Novartis Biosimilars Revenue, Sales, Ex-factory Price

Figure 2015 Novartis 2015 Biosimilars Business Region Distribution

Table Merck Information List

Table Type I Biosimilars Overview

Table Type II Biosimilars Overview

Table Type III Biosimilars Overview

Table 2015 Merck Biosimilars Revenue, Sales, Ex-factory Price

Figure 2015 Merck 2015 Biosimilars Business Region Distribution

Table 3sbio Information List

Table Type I Biosimilars Overview

Table Type II Biosimilars Overview

Table Type III Biosimilars Overview

Table 2015 3sbio Biosimilars Revenue, Sales, Ex-factory Price

Figure 2015 3sbio 2015 Biosimilars Business Region Distribution

Table Changchun High Tech Information List

Table Type I Biosimilars Overview

Table Type II Biosimilars Overview

Table Type III Biosimilars Overview

Table 2015 Changchun High Tech Biosimilars Revenue, Sales, Ex-factory Price

Figure 2015 Changchun High Tech 2015 Biosimilars Business Region Distribution

Table CP Guojian Information List

Table Type I Biosimilars Overview

Table Type II Biosimilars Overview

Table Type III Biosimilars Overview

Table 2015 CP Guojian Biosimilars Revenue, Sales, Ex-factory Price

Figure 2015 CP Guojian 2015 Biosimilars Business Region Distribution

Table Biotech Information List

Table Type I Biosimilars Overview

Table Type II Biosimilars Overview

Table Type III Biosimilars Overview

Table 2015 Biotech Biosimilars Revenue, Sales, Ex-factory Price

Figure 2015 Biotech 2015 Biosimilars Business Region Distribution

Table Gelgen Information List

Table Type I Biosimilars Overview

Table Type II Biosimilars Overview

Table Type III Biosimilars Overview

Table 2015 Gelgen Biosimilars Revenue, Sales, Ex-factory Price

Figure 2015 Gelgen 2015 Biosimilars Business Region Distribution

Table Innovent Information List

Table Type I Biosimilars Overview

Table Type II Biosimilars Overview

Table Type III Biosimilars Overview

Table 2015 Innovent Biosimilars Revenue, Sales, Ex-factory Price

Figure 2015 Innovent 2015 Biosimilars Business Region Distribution

Figure Global 2016-2021 Biosimilars Market Size (Volume) and Growth Rate Forecast

Figure Global 2016-2021 Biosimilars Market Size (Value) and Growth Rate Forecast

Figure Global 2016-2021 Biosimilars Sales Price (USD/Unit) Forecast

Figure North America 2016-2021 Biosimilars Consumption Volume and Growth Rate Forecast

Figure China 2016-2021 Biosimilars Consumption Volume and Growth Rate Forecast

Figure Europe 2016-2021 Biosimilars Consumption Volume and Growth Rate Forecast

Figure Southeast Asia 2016-2021 Biosimilars Consumption Volume and Growth Rate Forecast

Figure Japan 2016-2021 Biosimilars Consumption Volume and Growth Rate Forecast

Figure India 2016-2021 Biosimilars Consumption Volume and Growth Rate Forecast

Table Global Sales Volume (K Units) of Biosimilars by Types 2016-2021

Table Global Consumption Volume (K Units) of Biosimilars by Applications 2016-2021

Table Traders or Distributors with Contact Information of Biosimilars by Regions

Table Part of Interviewees Record List

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Contact Us

+ 1-888-961-4454

Drop Us an email at

help@bigmarketresearch.com

Similar Reports

Protein Therapeutics Market by Product (Monoclonal Antibodies, Insulin, Fusion Protein, Erythropoietin, Interferon, Human Growth Hormone, and Follicle Stimulating Hormone) and Application (Metabolic Disorders, Immunologic Disorders, Hematological Disorders, Cancer, Hormonal Disorders, Genetic Disorders, and Others) - Global Opportunity Analysis and Industry Forecast, 2017-2023

Proteins that are designed and engineered in the laboratory for pharmaceutical interventions to treat different diseases are known as protein therapeutics. The global protein therapeutics market accounted for $140,109 million in 2016, and is anticipated to rea...

  • Publish Date: November 14, 2017
  • $5370
Global Cord Blood Banking Services (Stem Cell) Market, Size, Share, Trends, Forecast, Global Analysis, Research, Report, Segmentation, and Future Demand, 2012 - 2020

Umbilical cord blood bank is storage facility that collects cord blood after the childbirth from placenta. Cord blood is rich source of stem cell used in treatment of different chronic diseases. Private and public cord blood banks are the two major types of banks that are prevalent in th...

  • Publish Date: July 20, 2017
  • $5370